Catalyst OrthoScience Features Innovative Products and Shoulder Surgery Leaders at AAOS

Visit booth #2408 for product demonstrations of the Archer™ Shoulder Systems

March 22, 2022

NAPLES, Fla.–(BUSINESS WIRE)–Catalyst OrthoScience Inc. (Catalyst), a medical device company focused on the upper extremity orthopedics market, will be at the American Academy of Orthopedic Surgeons (AAOS) 2022 Annual Meeting, March 23-25, 2022, in Chicago. At booth #2408, Catalyst will have demos and the latest information to share about its latest products, including the Archer CSR Total Shoulder System, Archer R1 Reverse Shoulder System, as well as the Archer 3D Targeting imaging software that supports preoperative planning for shoulder arthroplasty.

At the Catalyst booth, attendees can experience the Catalyst Clinical Series featuring:

  • “Subscapularis-Sparing Approach To Perform Anatomic TSA Using A Multiplanar Humeral Osteotomy And Angled Glenoid Instruments” presented by Steven Goldberg, MD of Physicians Regional Medical Group on Wednesday, March 23 from 1:00 – 1:30 pm CT
  • “Improved Range of Motion Using Stemless, Ellipsoid TSA System Compared To Standard TSA” presented by Matthew Budge, MD of Kaiser Permanente NW on Thursday, March 24 from 10:30 – 11:00 am CT

Catalyst will also have the following presentations at its product reception on Thursday, March 24. Details regarding the product reception will be available at the company’s booth.

  • “The Future of Catalyst OrthoScience” presented by Carl O’Connell, CEO and president, Catalyst OrthoScience
  • “The Evolution Of TSA To A Stemless, Ellipsoid Future” presented by Theodore Blaine, MD, Hospital for Special Surgery (HSS), New York, NY
  • “Making The Switch: Moving To The Archer™ Shoulder Systems” presented by Aaron Bare, MD, Northwestern Medicine Regional Medical Group, Warrenville, IL

“Catalyst OrthoScience has experienced significant, industry-leading growth over the past few years, and we are poised to continue to build momentum in 2022,” said Carl O’Connell, CEO and president at Catalyst OrthoScience. “We are excited to bring these leading shoulder surgeons together to discuss trending topics in shoulder arthroplasty and the benefits of our Archer Shoulder Systems.”

Catalyst is disrupting the usual approaches to shoulder replacement surgery. The Archer CSR Total Shoulder System is unique, offering precision and accuracy in shoulder restoration while preserving the patient’s bone and soft tissue. The Archer R1 Reverse Shoulder System is a single-tray arthroplasty system that offers surgeon-targeted implant positioning, a streamlined and versatile system, and bone sparing implants. At Catalyst, our goal is to develop innovative medical solutions that make orthopedic surgery less invasive and more efficient for both surgeons and patients.

For more information about Catalyst and its Archer suite of solutions, visit booth #2408 at AAOS or www.CatalystOrtho.com.

About Catalyst OrthoScience Inc.

Catalyst OrthoScience, founded in 2014 by orthopedic surgeon Steven Goldberg, M.D., improves the patient and surgeon experience by making shoulder surgery less invasive and more efficient. The company has a growing portfolio of U.S. and international patents and pending patents on its distinctive surgical offerings. Headquartered in Naples, Fla., Catalyst products are available across the U.S. For more information, visit www.CatalystOrtho.com/.


Wendy Crites Wacker, APR, CPRC
Catalyst OrthoScience
(352) 494-2129

Chris J. Stewart

Chris currently serves as President and CEO of Surgio Health. Chris has close to 20 years of healthcare management experience, with an infinity to improve healthcare delivery through the development and implementation of innovative solutions that result in improved efficiencies, reduction of unnecessary financial & clinical variation, and help achieve better patient outcomes. Previously, Chris was assistant vice president and business unit leader for HPG/HCA. He has presented at numerous healthcare forums on topics that include disruptive innovation, physician engagement, shifting reimbursement models, cost per clinical episode and the future of supply chain delivery.

Related Articles

Back to top button